S Dietz1, C Lautenschläger2, U Müller-Werdan3, G Pilz4, P Fraunberger5, M Päsler6, H Ebelt7, A K Walli8, K Werdan9, S Nuding10. 1. Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, St. Marien-Krankenhaus Siegen gem. GmbH, Kampenstraße 51, 57072, Siegen, Germany. 2. Institut für Medizinische Epidemiologie, Biometrie und Informatik, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Straße 8, 06112, Halle (Saale), Germany. 3. Evangelisches Geriatriezentrum Berlin gGmbH, Reinickendorfer Str. 61, 13347, Berlin, Germany. 4. Klinik für Kardiologie, Krankenhaus Agatharied, Norbert-Kerkel-Platz, 83734, Hausham, Germany. 5. Medizinisches Zentrallabor, Carinagasse 41, 6800, Feldkirch/Vorarlberg, Austria. 6. Medizinische Klinik 8, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Germany. 7. Klinik für Innere Medizin II, Katholisches Krankenhaus St. Johann Nepomuk, Haarbergstraße 72, 99097, Erfurt, Germany. 8. Institut für Klinische Chemie, Klinikum der Universität München, Marchionistraße 15, 81377, München, Germany. 9. Klinik für Innere Medizin III, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum Halle (Saale), Ernst-Grube-Straße 40, 06120, Halle (Saale), Germany. 10. Klinik für Innere Medizin III, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum Halle (Saale), Ernst-Grube-Straße 40, 06120, Halle (Saale), Germany. sebastian.nuding@uk-halle.de.
Abstract
BACKGROUND: The role of intravenous immune globulin (Ig) therapy in patients with severe sepsis and septic shock is discussed controversially. Low initial IgG levels could help to identify those patients who might benefit from an adjunctive Ig treatment. OBJECTIVES: To investigate the effect of initial serum IgG levels on 28-day mortality in patients with severe sepsis and septic shock. MATERIALS AND METHODS: In this retrospective analysis of the SBITS trial data, 543 patients were allocated to four groups (quartiles) depending on their initial serum IgG levels (1: IgG ≤ 6.1 g/l; 2: IgG 6.2-8.4 g/l; 3: IgG 8.5-11.9 g/l; 4: IgG > 11.9 g/l). The third quartile was taken as the reference quartile. For the applied logistic regression model clinically relevant confounders were defined and integrated into further risk-adjusted calculations. RESULTS: Patients with the lowest IgG levels had a mortality rate similar to those patients with initial IgG levels in the second and third quartile, representing the physiological IgG range in healthy people. Surprisingly, patients with the highest IgG levels even showed a significantly higher mortality in a risk-adjusted calculation compared to the reference quartile (OR 1.69, CI 1.01-2.81, p = 0.05). Subgroup analyses revealed that initial IgG levels were of no prognostic value in patients presenting with vasopressor-dependent septic shock on admission as well as in patients with either gram-positive or gram-negative sepsis. CONCLUSIONS: Initially low IgG levels do not discriminate between survival and nonsurvival in patients with severe sepsis and septic shock. Therefore, low IgG cannot help to identify those patients who might benefit from an adjunctive IgG sepsis therapy. Whether a high initial IgG serum level is an independent mortality risk factor needs to be investigated prospectively.
BACKGROUND: The role of intravenous immune globulin (Ig) therapy in patients with severe sepsis and septic shock is discussed controversially. Low initial IgG levels could help to identify those patients who might benefit from an adjunctive Ig treatment. OBJECTIVES: To investigate the effect of initial serum IgG levels on 28-day mortality in patients with severe sepsis and septic shock. MATERIALS AND METHODS: In this retrospective analysis of the SBITS trial data, 543 patients were allocated to four groups (quartiles) depending on their initial serum IgG levels (1: IgG ≤ 6.1 g/l; 2: IgG 6.2-8.4 g/l; 3: IgG 8.5-11.9 g/l; 4: IgG > 11.9 g/l). The third quartile was taken as the reference quartile. For the applied logistic regression model clinically relevant confounders were defined and integrated into further risk-adjusted calculations. RESULTS:Patients with the lowest IgG levels had a mortality rate similar to those patients with initial IgG levels in the second and third quartile, representing the physiological IgG range in healthy people. Surprisingly, patients with the highest IgG levels even showed a significantly higher mortality in a risk-adjusted calculation compared to the reference quartile (OR 1.69, CI 1.01-2.81, p = 0.05). Subgroup analyses revealed that initial IgG levels were of no prognostic value in patients presenting with vasopressor-dependent septic shock on admission as well as in patients with either gram-positive or gram-negative sepsis. CONCLUSIONS: Initially low IgG levels do not discriminate between survival and nonsurvival in patients with severe sepsis and septic shock. Therefore, low IgG cannot help to identify those patients who might benefit from an adjunctive IgG sepsis therapy. Whether a high initial IgG serum level is an independent mortality risk factor needs to be investigated prospectively.
Authors: Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Lisa A Weissfeld; Francis Pike; Thomas Terndrup; Henry E Wang; Peter C Hou; Frank LoVecchio; Michael R Filbin; Nathan I Shapiro; Derek C Angus Journal: N Engl J Med Date: 2014-03-18 Impact factor: 91.245
Authors: F M Brunkhorst; P Gastmeier; W Kern; W Krüger; K Mayer; A Weimann; T Welte; C Putensen; K Werdan; K Reinhart Journal: Internist (Berl) Date: 2010-07 Impact factor: 0.743
Authors: Fabio Silvio Taccone; Patrick Stordeur; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent Journal: Shock Date: 2009-10 Impact factor: 3.454
Authors: Karl Werdan; Günter Pilz; Ursula Müller-Werdan; Monika Maas Enriquez; Dierk V Schmitt; Friedrich-Wilhelm Mohr; Gertraud Neeser; Friedrich Schöndube; Hans-Joachim Schäfers; Axel Haverich; Peter Fraunberger; Jan Andersson; Eckart Kreuzer; Lambert G Thijs Journal: Crit Care Med Date: 2008-03 Impact factor: 7.598
Authors: Gudrun Larscheid; Tino Schulz; Hermann Herbst; Tina Trögel; Sascha Eulert; Axel Pruß; Jan Schroeter Journal: Transfus Med Hemother Date: 2021-01-05 Impact factor: 3.747
Authors: Ignacio Martin-Loeches; Arturo Muriel-Bombín; Ricard Ferrer; Antonio Artigas; Jordi Sole-Violan; Leonardo Lorente; David Andaluz-Ojeda; Adriele Prina-Mello; Ruben Herrán-Monge; Borja Suberviola; Ana Rodriguez-Fernandez; Pedro Merino; Ana M Loza; Pablo Garcia-Olivares; Eduardo Anton; Eduardo Tamayo; Wysali Trapiello; Jesús Blanco; Jesús F Bermejo-Martin Journal: Ann Intensive Care Date: 2017-04-20 Impact factor: 6.925
Authors: Stefanie Prohaska; Andrea Schirner; Albina Bashota; Andreas Körner; Gunnar Blumenstock; Helene A Haeberle Journal: J Intensive Care Date: 2018-02-26